Drug Shortage Report for BETOPTIC S
Report ID | 106958 |
Drug Identification Number | 01908448 |
Brand name | BETOPTIC S |
Common or Proper name | BETOPTIC S 0.25% SUSP 5ML |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | BETAXOLOL |
Strength(s) | .25% |
Dosage form(s) | SUSPENSION |
Route of administration | OPHTHALMIC |
Packaging size | 5ML |
ATC code | S01ED |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2020-02-21 |
Estimated end date | 2020-04-17 |
Actual end date | 2020-04-20 |
Shortage status | Resolved |
Updated date | 2020-04-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v15 | 2020-04-21 | English | Compare |
v14 | 2020-04-20 | French | Compare |
v13 | 2020-04-20 | English | Compare |
v12 | 2020-03-31 | French | Compare |
v11 | 2020-03-31 | English | Compare |
v10 | 2020-03-20 | French | Compare |
v9 | 2020-03-20 | English | Compare |
v8 | 2020-03-09 | French | Compare |
v7 | 2020-03-09 | English | Compare |
v6 | 2020-02-24 | French | Compare |
v5 | 2020-02-24 | English | Compare |
v4 | 2020-02-22 | English | Compare |
v3 | 2020-02-21 | French | Compare |
v2 | 2020-02-21 | English | Compare |
v1 | 2020-02-21 | English | Compare |
Showing 1 to 15 of 15